These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24517415)

  • 1. Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B.
    Wu H; Zhao G; Qian F; Liu K; Xie J; Zhou H; Xu J; Xu Y; Han Y; Xie Q; Wang H
    Liver Int; 2015 Feb; 35(2):473-81. PubMed ID: 24517415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B.
    Sonneveld MJ; Wong VW; Woltman AM; Wong GL; Cakaloglu Y; Zeuzem S; Buster EH; Uitterlinden AG; Hansen BE; Chan HL; Janssen HL
    Gastroenterology; 2012 Mar; 142(3):513-520.e1. PubMed ID: 22108195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B.
    Wei L; Wedemeyer H; Liaw YF; Chan HL; Piratvisuth T; Marcellin P; Jia J; Tan D; Chow WC; Brunetto MR; Diago M; Gurel S; Morozov V; He H; Zhu Y; Wat C; Surujbally B; Thompson AJ
    PLoS One; 2018; 13(7):e0199198. PubMed ID: 30016335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL28B genotype is not useful for predicting treatment outcome in Asian chronic hepatitis B patients treated with pegylated interferon-α.
    Holmes JA; Nguyen T; Ratnam D; Heerasing NM; Tehan JV; Bonanzinga S; Dev A; Bell S; Pianko S; Chen R; Visvanathan K; Hammond R; Iser D; Rusli F; Sievert W; Desmond PV; Bowden DS; Thompson AJ
    J Gastroenterol Hepatol; 2013 May; 28(5):861-6. PubMed ID: 23301835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of IL28B and
    Domagalski K; Pawłowska M; Zaleśna A; Pilarczyk M; Rajewski P; Halota W; Tretyn A
    World J Gastroenterol; 2016 Nov; 22(41):9186-9195. PubMed ID: 27895405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon.
    Boglione L; Cusato J; Allegra S; Esposito I; Patti F; Cariti G; Di Perri G; D'Avolio A
    Antiviral Res; 2014 Feb; 102():35-43. PubMed ID: 24316030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of IPS1 polymorphisms with peginterferon efficacy in chronic hepatitis B with HBeAg-positive in the Chinese population.
    Wang H; Wu H; Bao S; Xiang X; Zhao G; Liu K; Li F; Xu Y; An B; Zhou H; Lu J; Xie Q
    Infect Genet Evol; 2015 Apr; 31():161-8. PubMed ID: 25640825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B.
    Lampertico P; Viganò M; Cheroni C; Facchetti F; Invernizzi F; Valveri V; Soffredini R; Abrignani S; De Francesco R; Colombo M
    Hepatology; 2013 Mar; 57(3):890-6. PubMed ID: 22473858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients.
    Heo NY; Lim YS; Lee W; Oh M; An J; Lee D; Shim JH; Kim KM; Lee HC; Lee YS; Suh DJ
    Clin Mol Hepatol; 2014 Jun; 20(2):177-84. PubMed ID: 25032184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between IL-28B polymorphisms and the response to peginterferon alfa-2a monotherapy in anti-HBe-positive patients with chronic HBV infection.
    Domagalski K; Pawłowska M; Zaleśna A; Tyczyno M; Skorupa-Kłaput M; Tretyn A; Halota W
    Eur J Clin Microbiol Infect Dis; 2014 Nov; 33(11):2025-33. PubMed ID: 24924923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL28B polymorphism correlates with active hepatitis in patients with HBeAg-negative chronic hepatitis B.
    Lee IC; Lin CH; Huang YH; Huo TI; Su CW; Hou MC; Huang HC; Lee KC; Chan CC; Lin MW; Lin HC; Lee SD
    PLoS One; 2013; 8(2):e58071. PubMed ID: 23469142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype F of hepatitis B: response to interferon.
    Venegas M; Poniachik J; Fuster F; Hurtado C; Villanueva RA; Brahm J
    Antivir Ther; 2015; 20(4):453-6. PubMed ID: 25321866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population.
    Li W; Jiang Y; Jin Q; Shi X; Jin J; Gao Y; Pan Y; Zhang H; Jiang J; Niu J
    Liver Int; 2011 Sep; 31(8):1118-26. PubMed ID: 21745278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peginterferon α in the treatment of chronic hepatitis B.
    Tseng TC; Kao JH; Chen DS
    Expert Opin Biol Ther; 2014 Jul; 14(7):995-1006. PubMed ID: 24738850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.
    Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y
    Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of
    Świątek-Kościelna B; Kałużna E; Strauss E; Nowak J; Bereszyńska I; Gowin E; Wysocki J; Rembowska J; Barcińska D; Mozer-Lisewska I; Januszkiewicz-Lewandowska D
    World J Gastroenterol; 2017 Jun; 23(21):3815-3824. PubMed ID: 28638221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients.
    Zhang Q; Lapalus M; Asselah T; Laouénan C; Moucari R; Martinot-Peignoux M; Bieche I; Estrabaud E; De Muynck S; Boyer N; Bedossa P; Vidaud M; Marcellin P; Lada O
    J Viral Hepat; 2014 Jul; 21(7):525-32. PubMed ID: 24118626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interleukin 28B-related gene polymorphisms in chronic hepatitis C and the response to antiviral therapy in Koreans.
    Jung YK; Kim JH; Ahn SM; Yang JW; Park SJ; Kim JW; Yeon JE; Kwon OS; Kim YS; Choi DJ; Kim JH; Byun KS
    J Clin Gastroenterol; 2013 Aug; 47(7):644-50. PubMed ID: 23442843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL28B genetic variations are associated with treatment response of patients with chronic hepatitis C in a Chinese Han population.
    Dong ZX; Zhou HJ; Xiang XG; Guo SM; Zhuang Y; Zhao GD; Xie Q
    J Dig Dis; 2015 Feb; 16(2):90-7. PubMed ID: 25312023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single Nucleotide Polymorphism of Interferon Lambda-4 Gene is not Associated with Treatment Response to Pegylated Interferon in Thai Patients with Chronic Hepatitis B.
    Limothai U; Wasitthankasem R; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(13):5515-9. PubMed ID: 26225703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.